Zephyrnet Logo

Tag: homegrown

Mobile Premier League (MPL) Acquires German Game Studio GameDuell

India’s homegrown esports and skill gaming company, Mobile Premier League (MPL) makes inroads into Europe by acquiring Germany-based game studio, GameDuell for an undisclosed amount.  The acquisition goes in line with MPL’s expansion strategy which the company had announced last year. With GameDuell onboard, MPL now has an international presence in Asia, Europe, and the […]

The post Mobile Premier League (MPL) Acquires German Game Studio GameDuell appeared first on TalkEsport.

Cannabis Is The Top Job Creator In America Right Now — Here Are The Stats

Cannabis Is The Top Job Creator In America Right Now — Here Are The Stats

There are more people employed in the cannabis industry than there are hairstylists, barbers and cosmetologists combined.

The post Cannabis Is The Top Job Creator In America Right Now — Here Are The Stats appeared first on The Fresh Toast.

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

SINGAPORE, Feb 23, 2022 - (ACN Newswire) - Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021"). The Group reported a net loss after tax of RMB7.3 million for FY2021, an improvement from the net loss of RMB12.1 million from a year ago. In 2020, in view of COVID-19 situation, the Chinese government provided temporary relief to businesses by waiving the social security insurance contributions. Aoxin would have additional RMB6.3 million of social security insurance expenses recorded in FY2020 resulting in a Net Loss of RMB18.4 million, instead of RMB12.1 million.


Dr. Shao Yongxin, Group Chief Executive Officer of Aoxin Q&M said, "Global economic prospects for 2022 will continue to be uncertain, with many countries still struggling to contain the rapid spread of the Omicron variant. The possibility of new COVID-19 strains cannot be ruled out. However, Aoxin Q&M's dental services make it resilient and well-positioned ride out the current downturn to capitalize on strategic opportunities in the post-COVID healthcare sector".

Mr Ryan San, Deputy Chief Executive Officer of Aoxin Q&M said, "The Group has been operating in a challenging environment, severely impacted by the recurring lockdowns of entire cities in the People's Republic of China ("PRC"). We are keeping a close watch on the evolving COVID-19 situation in PRC, while managing our costs with strict discipline."

Revenue

The Group's revenue increased by RMB27.6 million or 20.8%, from RMB132.6 million in FY2020 to RMB160.2 million in FY2021, mainly due to the recovery in all business segments.

Revenue from primary healthcare segment increased by 19.7% from RMB78.5 million in FY2020 to RMB93.9 million in FY2021. The increase in revenue were from our key hospitals in Shenyang and Dalian cities, and a polyclinic in Panjin city mainly due to increase in patients.

Revenue from distribution of dental equipment and supplies segment achieved a significant growth of 24.8%. Revenue was RMB50.4 million in FY2021 as compared to RMB40.4 million in FY2020. There was a higher demand for dental supplies materials from government hospitals amidst a gradual economic recovery in China backed by rolling out of the COVID-19 vaccination in the country.

Revenue from laboratory services segment increased by 15.9% to RMB15.9 million in FY2021 as compared to RMB13.7 million in FY2020 due to increase in demand of such services from the government dental hospitals in Shenyang City.

EBITDA

The Group's EBITDA also increased from RM9.5 million in FY2020 to RMB13.9 million in FY2021. The increase in EBITDA was mainly attributable to higher revenue and better performance from key dental hospitals and polyclinics as well as higher sales for dental equipment and supplies. Despite a positive EBITDA of RMB13.9 million, the Group recorded a loss of RMB7.3 million due to salary increment and recruitment expenses, as well as higher other expenses, such as acquisition related fees for Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics") and other tax expenses.

Mr Ryan San, Deputy Chief Executive Officer of Aoxin Q&M added. "We are also hopeful that moving forward, our recent acquisition of a 49% stake in Acumen Diagnostics will improve the profitability and cashflow of the Group. With Acumen Diagnostics expertise in R&D and medical diagnostics we will be able to play a vital role in support of the Singapore government's strategy of living with COVID-19. Concomitantly, this will also contribute to the growth of the Group."

Updates on associate - Acumen Diagnostics

- Capabilities to Tackle Omicron COVID-19 Variant

Acumen Diagnostics will continue to offer COVID-19 testing by polymerase chain reaction ("PCR") for patients that require PCR test results and for travelers as Singapore opens its borders, as well as distribute COVID-19 antigen rapid tests ("ART"). It will also launch a panel of new PCR tests for infectious diseases, sepsis and cancer.

On 3 December 2021, Acumen Diagnostics announced that its proprietary, locally-manufactured PCR test kits Acu-Corona 2.0 and Acu-Corona Duplex are able to detect COVID-19 positive cases infected with the Omicron variant. On 16 December 2021, Acumen Diagnostics announced that it has been granted a license by Ministry of Health, Singapore to provide offsite COVID-19 PCR swab services and serology sample collection at 100 clinics.

Acumen Diagnostics will continue to roll out its testing services via the Q&M Dental Group Limited's network of clinics, and also at its headquarters located at The Gemini, 41 Science Park Road, Singapore. Currently, Acumen Diagnostics has about 61 clinics providing the testing services island-wide.

- Proposed listing on NASDAQ stock exchange in relation to Acumen Diagnostics Pte. Ltd.

On 17 January 2022, Aoxin announced that the associated company of the Group, Acumen Diagnostics is exploring a proposed listing of its securities on the NASDAQ stock exchange in New York, USA. In this regard, Acumen Diagnostics has appointed UOB Kay Hian Private Limited to assist Acumen Diagnostics with the listing evaluation and all relevant preparatory work including the selection of professional advisers and underwriting banks in relation to the proposed listing and fund-raising exercise.

Looking Forward

Aoxin's FY2021 results reflects the significant upturn in revenue as compared to FY2020 revenue which was the period when the COVID-19 pandemic in PRC was in a more serious phase. As the COVID-19 situation in the PRC continues to improve, we expect the Group's revenue to correspondingly improve.

In addition, the recent 49% acquisition of medical technology company, Acumen Diagnostics for S$29.4 million on 1 November 2021, will enhance the profitability of the Group going forward.

The business environment is expected to remain challenging for the year ahead, as many countries including PRC struggle to contain the rapid spread of the COVID-19 virus demonstrated by new waves of infections.

The Group will continue to focus on disciplined management of operating expenditures, costs and capital expenditures. The Group will continue to monitor its expenses and maximise cost efficiency for operations.

Barring any unforeseen circumstances and further worsening of the COVID-19 situation such as ad-hoc lock down or temporary closures in cities where we operate, there are no known significant changes in the trends and competitive conditions of the industry in which the Group operates and no other major known factors or events that may adversely affect the Group in the next reporting period and the next 12 months. The Group will continue to monitor its operating expenses and maximise cost efficiency for operations.

For more information, please see attached files or the below links:
https://links.sgx.com/FileOpen/AoxinPressRelease-FY2021_final_23.2.22.ashx?App=Announcement&FileID=703172
https://links.sgx.com/FileOpen/AXQM%20Announcement%20FY2021.ashx?App=Announcement&FileID=703171

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms. Lim Hui Ling, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, sponsorship@ppcf.com.sg

About Aoxin Q&M Dental Group Limited (Stock Code: 1D4.SI) www.aoxinqm.com.sg

Aoxin Q&M Dental Group Limited ("Aoxin Q&M" or together with its subsidiaries, the "Group") is a leading provider of private dental services in the Liaoning Province, Northern People's Republic of China ("PRC"). The Group operates 16 dental centres, comprising 10 dental polyclinics and 6 dental hospitals, located across 8 cities in Liaoning Province, namely Shenyang, Huludao, Panjin, Gaizhou, Zhuanghe, Jinzhou, Dalian and Anshan.

We currently have 400 dental professionals, including 170 dentists, 180 dental surgery assistants and 50 laboratory technicians.

A majority of the dental centres are accredited as Designated Medical Institutions of Medical Insurance. Additionally, the Group is engaged in the provision of dental laboratory services, as well as the distribution and sale of dental equipment and supplies in the Liaoning, Heilongjiang and Jilin Provinces in Northern PRC.

Aoxin Q&M was listed on the Catalist board of the Singapore Exchange Securities Trading Limited on 26 April 2017.

About Acumen Diagnostics Pte. Ltd. (www.acumen-research.com)

Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics") is a homegrown Singaporean, award-winning medical technology company. It is fully integrated with functions in research and development, manufacturing, as well as commercialisation of molecular diagnostics by distribution as well as conducting clinical laboratory testing services for (including but not limited to) infectious diseases, cancer, and COVID-19. It has also actively established frontline services such as COVID-19 on-site swabbing operations.

Acumen Diagnostics is a 51% subsidiary of SGX-listed Q&M Dental Group (Singapore) Limited (SGX: 1D4.SI) and 49%-owned by SGX-listed Aoxin Q&M Dental Group Limited (SGX: QC7.SI).

Media and Analysts: please contact below for more information: Waterbrooks Consultants Pte. Ltd.
+65 6958 8008, query@waterbrooks.com.sg
Wayne Koo (M): +65 9338 8166, wayne.koo@waterbrooks.com.sg
Derek Yeo (M): +65 9791 4707, derek@waterbrooks.com.sg

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comCatalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").

Kiwibank turns to tech partners to fend off Aussies

The retail bank is adopting cloud-based, real-time payments in a renewed bid to win market share.

The post Kiwibank turns to tech partners to fend off Aussies appeared first on Digital Finance.

AMD Skyesports BGMI Grand Slam sets new viewership records on Loco

AMD Skyesports Grand Slam was the first big BGMI event of the year and on the Skyesports 2022 roadmap. The popularity of this event soared new heights as the broadcasting meta was slightly shifted. Due to the intense competition and incredible production, Grand Slam 2022 set a new record for Skyesports and Loco by reaching […]

The post AMD Skyesports BGMI Grand Slam sets new viewership records on Loco appeared first on TalkEsport.

India reportedly bans mobile esport title Garena Free Fire 

The Indian government has reportedly banned popular mobile esport title Garena Free Fire alongside a wave of 53 other blocked applications, according to Indian outlet ET NOW. The applications have allegedly been blocked on the grounds that they pose a threat to India’s national security, as stated by Indian news agency ANI. RELATED: PUBG Mobile […]

Friday ‘Nite: Let’s Fan-Cast The Fortnite Movie

A Fortnite movie is coming. No, that's not an announcement, though there have been rumors of a Fortnite movie for some time now. But it's practically a foregone conclusion that one of the biggest names in entertainment, a brand with its hand in basically every intellectual property money pit right now, from Star Wars to Marvel and much more, is going to get a movie. It's merely a matter of time.

One could argue that a movie is an old-fashioned way of doing things. Fortnite already features some incredible cinematic live events that players can live through themselves, which ends up feeling quite like being in a Fortnite movie already. But I do think, even in this weird era for movie theaters, that a Fortnite movie would be massive. It's important to capitalize on the game's still sky-high popularity, lest Epic Games and partners risk launching it when the game is losing steam, like the Angry Birds Movie.

With so many crossovers and characters constantly coming to Fortnite, no doubt a Fortnite movie would be packed full of more collaborations than Ready Player One, but for this exercise, I'm going to focus just on Fortnite's homegrown heroes and largely pull from the most important characters in Fortnite lore, such as Jonesy, Doctor Slone, and Midas. Whether it's a live-action adaptation or an animated feature with a star-studded voice cast, here's who I envision as the stars of the inevitable Fortnite movie.

Jonesy - Tom Holland

Gallery Gallery image 1 Gallery image 2

Holland is already the famous face of Spider-Man and Nathan Drake on the big screen, but if you think he can't also play the main character of the Fortnite movie, I'd have to guess you haven't heard what Chris Pratt's been up to. Holland suits Jonesy's mix of a young everyman with some jokey reluctant hero tropes that he's already doing well in his other movies. As with his role as Drake, he's also young enough to play Jonesy for the years of sequels to come.

The Foundation - The Rock

Gallery Gallery image 1 Gallery image 2

No need to get cute here. The Rock is already playing the muscular leader of The Seven in Fortnite, and there's every reason to think he'd fulfill that role in the movie version too. The Rock has star power like few others, appealing to both kids and adults dating back to his WWF days. It's a shine he's never really lost, and he'd play off of Holland perfectly in the same buddy-cop way that The Foundation and Jonesy already do in the game.

Doctor Slone - Jasmin Savoy Brown

Gallery Gallery image 1 Gallery image 2

Jasmine Savoy Brown's last half-decade has seen her catapulted into the upper echelon of young stars, and hers is a star still rising. She's already flexed her ability to play complicated morally dubious characters in projects like The Leftovers, Scream, and Yellowjackets, so she'd fit right in as the probably evil, but maybe misunderstood Doctor Slone.

The Cube Queen - Carrie-Anne Moss

Gallery Gallery image 1 Gallery image 2

Coming off back-to-back high-profile roles in The Matrix Resurrections and Horizon Forbidden West, Carrie Ann Moss makes a lot of sense as the formidable Cube Queen. This is a character who may not appear in the first Fortnite movie, assuming it rehashes the story to a predictable degree, but Moss would make for a big name attached to the sequel in the way studios love to do, and she's got the commanding energy the Cube Queen demands.

Midas - Oscar Isaac

Gallery Gallery image 1 Gallery image 2

One thing Epic got wrong about Midas, in my opinion, is that he's meant to be Jules' dad, but the two characters look nearly the same age. If the movie was live-action, that could be fixed by casting an older actor, but still someone who feels dripping with style and dangerous allure. Of course, I'm speaking of Oscar Isaac. He's the perfect age and would bring his soon-to-be-earned Marvel fandom with him.

Jules - Ariana Grande

Gallery Gallery image 1 Gallery image 2

This would be fun for a few reasons. For one, Grande is starting to try acting, as seen in Netflix's Don't Look Up recently. But more than that, Grande is already a big name in Fortnite thanks to her Rift Tour concert in the summer of 2021. For Grande to show up in the Fortnite movie as a character created by Epic would be a fun nod to the game's own internal history, not to mention Grande is a few fake tattoos away from resembling Jules pretty closely.

The Paradigm - Mackenzie Davis

At the time of writing this, Epic is still drip-feeding us story about why The Paradigm was cast out of The Seven (and why the group may now be considering bringing her back). It seems like the writers have big, big plans for this mysterious hero, and if that translates to the movie, you'll need a rising star to fill the role. After nailing it in things like Black Mirror and Station Eleven, I love Mackenzie Davis for this role. She's believable as a hero with a checkered past, which seems to be who Epic is telling us The Paradigm is.

The Scientist - Joel McHale

Gallery Gallery image 1 Gallery image 2

Like The Foundation, The Scientist's in-game voice actor could comfortably slide into the movie role just as well. Joel McHale has done a great job as The Scientist, bringing a comic relief character to the story that, while colorful and silly in general, tends to be about the universe collapsing in on itself when you really get down to the details. He's basically playing Jeff Winger from Community--but isn't he always? As sardonic as ever, McHale has the right amount of star power to fill out this cast.

Peely - Donald Glover

Gallery Gallery image 1 Gallery image 2

Look, if we're not gonna get the Community movie, then I'm using this as my own personal wishing well to reunite at least some of the cast in something. Glover has incredible comedic chops and would obviously kill it as the Fortnite world's anthropomorphic banana. Plus he'd do wonders with the eventual dancing banana segment that you've gotta know makes the final cut of any Fortnite movie. While we're at it, let's get Danny Pudi on the fitness fast-track to play Meowscles, Midas' buff cat, too.

The Fortnite universe is massive, so this is only a main cast, more or less. Who else would you like to see in an eventual Fortnite movie? If you like this sort of thing, join me every week for my weekly column dedicated to the Fortnite storyline, Friday 'Nite.

Camelot Group Big Favorite in £80B UK National Lottery Race

The UK Gambling Commission (UKGC) is backing the Camelot Group to retain its license to operate the UK National Lottery, The Telegraph reports. The regulator has recommended the group be awarded “preferred bidder” status in the ongoing tender process. Camelot has operated the lottery since its inception in 1994 and has successfully retained the contract […]

The post Camelot Group Big Favorite in £80B UK National Lottery Race appeared first on Casino.org.

Thailand Steps it Up with Decriminalized Cannabis & Home Growing

Different parts of the world move at their own pace when it comes to loosening restrictions on cannabis. Thailand has been pulling away from the rest of Asia, and was the first in the region to legalize cannabis for medical use. Now Thailand knocks it up a notch with decriminalized cannabis, and the ability for […]

The post Thailand Steps it Up with Decriminalized Cannabis & Home Growing appeared first on CBD Testers.

Thrive Technologies Launches Enlighten® Digital Analysis System…

A ground-breaking digital analysis system that leverages machine learning to help buyers visually see the dollar cost of lost sales, make meaningful changes and understand the decisions creating dead...

(PRWeb February 10, 2022)

Read the full story at https://www.prweb.com/releases/thrive_technologies_launches_enlighten_digital_analysis_system_to_help_distributors_identify_specific_causes_of_lost_sales_and_dead_stock/prweb18480477.htm

Valve Steam Deck wows reviewers: ‘The most innovative gaming PC in 20 years’

5 Advantages of Using a Computerized Accounting System for Your Company

As businesses grow, it’s par for the course for their operations to become more complex. They begin to handle more money, manage more staff and clients, and oversee a greater number of both major and minor business decisions. In particular, the volume and complexity of the accounting work a company needs to handle is sure […]

The post 5 Advantages of Using a Computerized Accounting System for Your Company appeared first on Fintech News.

Latest Intelligence

spot_img
spot_img